Clinical Evidence
Review important clinical evidence and professional society guidelines that emphasize the benefits of Dexcom Real-time Continuous Glucose Monitoring (rtCGM).
Clinical Studies
Highlighting key clinical evidence that demonstrates the positive impact of Dexcom rtCGM on clinical outcomes for people living with diabetes.
Dexcom G7 CGM System
Accuracy and Safety of Dexcom G7 rtCGM in Adults with Diabetes (Garg S et al, 2022)- Performance of the Dexcom G7 rtCGM System in Pregnant Women with Diabetes (Polsky S et al, 2024)
- Usability and Teachability of CGM Devices in Older Adults and Diabetes Educators (Psavko S et al, 2022)
Predictive Urgent Low Soon alert
- Real-World Hypoglycemia Avoidance with a CGM’s Predictive Low Glucose Alert (Puhr S et al, 2019)
- Mitigation of Rebound Hyperglycemia with rtCGM Data and Predictive Alerts (Acciaroli et al, 2022)
- Switching from isCGM to rtCGM with a Predictive Urgent Low Soon Alert Reduces Exposure to Hypoglycemia (Preechasuk L et al, 2024)
Type 1 diabetes
- Comparison of Different Treatment Modalities in 7 years of follow-up in the COMISAIR study (Šoupal J et al, 2023)
- Effect of switching from isCGM to rtCGM in adults with Type 1 diabetes: 24-month results from the ALERTT1 trial (Visser MM et al, 2023)
- Real-world glycemic outcomes in adult patients with type 1 diabetes using rtCGM compared to isCGM (Brown RE et al, 2022)
- Significant Reduction in Hypo Events in High-Risk MDI patients: The HypoDE Study (Heinemann L et al, 2018)
Type 2 diabetes
- The Dexcom Community Glucose Monitoring Project for People with Type 2 Diabetes—One-Year Outcomes (Grace T et al, 2024)
- The Potential Impact of CGM Use on Diabetes-Related Attitudes and Behaviors in Adults with Type 2 Diabetes (Clark T et al, 2024)
- rtCGM in high-risk people with insulin-requiring type 2 diabetes: A randomised controlled trial (Lever S et al, 2024)
- Comparing CGM and CBG in Adults with Inadequately Controlled, Insulin-Treated Type 2 diabetes: The Steno2tech Study (Lind N et al, 2024)
- Effect of rtCGM on Glycemic Control in Patients with Type 2 diabetes Treated with Basal Insulin: The MOBILE Study (Martens T et al, 2021)
Professional Society Guidelines
Highlighting the latest professional society guidelines and their recommendations for the use of rtCGM in patient protocols for people living with diabetes.
Canada
Diabetes Canada Recommendations for Glucose Monitoring in Adults and Children, 2021- Diabetes Canada Recommendations for Hypoglycemia in Adults, 2023
- Diabetes Canada Recommendations for Diabetes and Pregnancy, 2021
United States of America
United Kingdom
- NICE Quality Standard for Type 1 diabetes in adults, 2023
- NICE Quality Standard for Type 2 diabetes in adults, 2023
- NICE Quality Standard for Diabetes in children and young people, 2022
- NICE Quality Standard for Diabetes in pregnancy, 2023